NewImage


Published in the journal “Diabetologia”


http://link.springer.com/article/10.1007%2Fs00125-014-3429-z


Obesity is a global epidemic resulting from increased energy intake, which alters energy homeostasis and results in an imbalance in fat storage and breakdown. G0/G1 switch gene 2 (G0s2) has been recently characterised in vitro as an inhibitor of adipose triglyceride lipase (ATGL), the rate limiting step in fat catabolism. In the current study we aim to functionally characterise G0s2 within the physiological context of a mouse model.  We generated a mouse model in which G0s2 was deleted. The homozygous G0s2 knockout (G0s2/) mice were studied over a period of 22 weeks. Metabolic variables were measured including body weight and body composition, food intake, glucose and insulin tolerance tests, energy metabolism and thermogenesis.  

 

We report that G0s2 inhibits ATGL and regulates lipolysis and energy metabolism in vivo. G0s2/mice are lean, resistant to weight gain induced by a high-fat diet and are glucose tolerant and insulin sensitive. The white adipose tissue of G0s2/mice has enhanced lipase activity and adipocytes showed enhanced stimulated lipolysis. Energy metabolism in the G0s2/mice is shifted towards enhanced lipid metabolism and increased thermogenesis. G0s2/mice showed enhanced cold tolerance and increased expression of thermoregulatory and oxidation genes within white adipose tissue, suggesting enhanced browningof the white adipose tissue.  Our data show that G0s2 is a physiological regulator of adiposity and energy metabolism and is a potential target in the treatment of obesity and insulin resistance.

Advertisements